Prakash Chelladurai

769 total citations
15 papers, 450 citations indexed

About

Prakash Chelladurai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Prakash Chelladurai has authored 15 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Prakash Chelladurai's work include Pulmonary Hypertension Research and Treatments (9 papers), Peptidase Inhibition and Analysis (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Prakash Chelladurai is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Peptidase Inhibition and Analysis (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Prakash Chelladurai collaborates with scholars based in Germany, United States and United Kingdom. Prakash Chelladurai's co-authors include Soni Savai Pullamsetti, Werner Seeger, Kurt R. Stenmark, Uta‐Maria Bauer, Olivier Boucherat, Sébastien Bonnet, Michael Kracht, Frédéric Perros, Jason X.‐J. Yuan and Angelo D’Alessandro and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer Research and Scientific Reports.

In The Last Decade

Prakash Chelladurai

14 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prakash Chelladurai Germany 10 276 219 135 84 55 15 450
Pin-I Chen United States 6 381 1.4× 245 1.1× 109 0.8× 117 1.4× 43 0.8× 6 545
Josephine Pickworth United Kingdom 9 298 1.1× 177 0.8× 134 1.0× 120 1.4× 57 1.0× 15 454
Nathalie Mouraret France 5 228 0.8× 154 0.7× 69 0.5× 64 0.8× 33 0.6× 5 344
Rebecca Teske United States 6 151 0.5× 210 1.0× 125 0.9× 69 0.8× 31 0.6× 9 385
Maggie M. Zhu United States 6 338 1.2× 185 0.8× 162 1.2× 119 1.4× 29 0.5× 8 476
Eva Berghausen Germany 11 277 1.0× 156 0.7× 57 0.4× 127 1.5× 32 0.6× 20 419
James Iremonger United Kingdom 8 229 0.8× 256 1.2× 137 1.0× 68 0.8× 23 0.4× 12 443
Yu-Mee Kim United States 7 242 0.9× 117 0.5× 73 0.5× 71 0.8× 35 0.6× 7 347
Ewa Bieniek Poland 7 282 1.0× 119 0.5× 57 0.4× 88 1.0× 54 1.0× 13 421
Hiroko Deguchi Miyamoto Japan 7 138 0.5× 216 1.0× 112 0.8× 84 1.0× 41 0.7× 10 351

Countries citing papers authored by Prakash Chelladurai

Since Specialization
Citations

This map shows the geographic impact of Prakash Chelladurai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Chelladurai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Chelladurai more than expected).

Fields of papers citing papers by Prakash Chelladurai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Chelladurai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Chelladurai. The network helps show where Prakash Chelladurai may publish in the future.

Co-authorship network of co-authors of Prakash Chelladurai

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Chelladurai. A scholar is included among the top collaborators of Prakash Chelladurai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Chelladurai. Prakash Chelladurai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Datar, Sanjeev A., Emin Maltepe, Gary W. Raff, et al.. (2025). Microvascular preservation and cardiomyocyte hyperplasia underlie adaptive right ventricle development in congenital heart disease-pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 329(4). H907–H919.
2.
Zheng, Xiang, Poonam Sarode, Andreas Weigert, et al.. (2023). The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. Cancer Research. 83(14). 2345–2357. 31 indexed citations
3.
Hajji, Nabil, Sunniyat Rahman, John Wharton, et al.. (2023). Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology. American Journal of Respiratory and Critical Care Medicine. 208(8). 879–895. 18 indexed citations
4.
Chelladurai, Prakash, Carsten Kuenne, Alice Bourgeois, et al.. (2022). Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension. Science Translational Medicine. 14(648). eabe5407–eabe5407. 26 indexed citations
5.
Chelladurai, Prakash, Swati Dabral, Gergana Dobreva, et al.. (2020). Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension. Scientific Reports. 10(1). 12864–12864. 31 indexed citations
6.
Pullamsetti, Soni Savai, Prakash Chelladurai, Argen Mamazhakypov, et al.. (2020). Cancer and pulmonary hypertension: Learning lessons and real-life interplay. Global Cardiology Science and Practice. 2020(1). e202010–e202010. 9 indexed citations
7.
Chelladurai, Prakash, Olivier Boucherat, Kurt R. Stenmark, et al.. (2019). Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. British Journal of Pharmacology. 178(1). 54–71. 86 indexed citations
8.
Sarvari, Pouya, Prakash Chelladurai, Martina Korfei, et al.. (2017). The Role Of Histone Deacetylase 9 In Idiopathic Pulmonary Fibrosis. MPG.PuRe (Max Planck Society). 195. 1 indexed citations
9.
Sarode, Poonam, Andreas Weigert, Stefan Günther, et al.. (2017). Re-Education Of Tumor-Associated Macrophages By Modulating Histone Deacetylases In Lung Cancer. MPG.PuRe (Max Planck Society). 195. 1 indexed citations
10.
Chelladurai, Prakash, Werner Seeger, & Soni Savai Pullamsetti. (2016). Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives. European Respiratory Review. 25(140). 135–140. 32 indexed citations
11.
Pullamsetti, Soni Savai, Frédéric Perros, Prakash Chelladurai, Jason X.‐J. Yuan, & Kurt R. Stenmark. (2016). Transcription Factors, Transcriptional Coregulators, and Epigenetic Modulation in the Control of Pulmonary Vascular Cell Phenotype: Therapeutic Implications for Pulmonary Hypertension (2015 Grover Conference Series). Pulmonary Circulation. 6(4). 448–464. 38 indexed citations
14.
Plecitá‐Hlavatá, Lydie, Jan Tauber, Min Li, et al.. (2015). Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 55(1). 47–57. 55 indexed citations
15.
Chelladurai, Prakash, Werner Seeger, & Soni Savai Pullamsetti. (2012). Matrix metalloproteinases and their inhibitors in pulmonary hypertension. European Respiratory Journal. 40(3). 766–782. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026